A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder. Sullivan MA, Bisaga A, Pavlicova M, Carpenter KM, Choi CJ, Mishlen K, Levin ...

Acceptability and efficacy of naltrexone for criminal justice‐involved individuals with opioid use disorder: a systematic review and meta‐analysis. Bahji, A., Carlone, D., and Altomare, J. ( 2019)  Addiction, doi.org/10.1111/add.14946. Abs...

Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison. Friedmann PD, Wilson D, Hoskinson R Jr, Poshkus M, Clarke JG. J Subst Abuse Treat. 2018 Feb;85:45-48. doi: 10.1016/j.jsat.2017.04.010. ...

Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail. Velasquez M, Flannery M, Badolato R, Vittitow A, McDonald RD, Tofighi B, Garment AR, Giftos J, Lee JD. Addict Sci Clin Pract. 2019 O...

Rizmoic / Nalmedine 200 Mikrogramm Filmtabletten - ZUSAMMENFASSUNG DER MERKMALE DES ARZNEIMITTELS Rizmoic wird angewendet zur Behandlung von Opioid-induzierter Obstipation (OIC, opioid-induced constipation) bei Erwachsenen, die früher bereits mit...

A Review of Samidorphan: A Novel Opioid Antagonist. Chaudhary AMD, Khan MF, Dhillon SS, Naveed S. Cureus. 2019 Jul 15;11(7):e5139. doi: 10.7759/cureus.5139. Review. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741386/